Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
TrueBlue, Inc. (NYSE: TBI)
TBI Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-1.50%
Analyst Rating:
BUY
Analyst Forecast (1yr):
-11%
TBI Stock Analysis
TBI
PE Ratio:
TBI
PEG Ratio:
Not Available
TBI
Forward EPS Growth (12 month):
0.00%
TBI
PS Ratio:
0.1
TBI
PSG Ratio:
TBI
Forward Revenue Growth (12 month):
4.10%
TBI Articles
No data was found